Synthesis and In Vitro Screening of Novel Heterocyclic Compounds as Potential Breast Cancer Agents

Penthala, Narsimha Reddy; Yerramreddy, Thirupathi Reddy; Madadi, Nikhil Reddy; Sonar, Vijayakumar N.; Crooks, Peter A.

doi:10.5772/21838

Breast Cancer - Current and Alternative Therapeutic Modalities 2011

DOI: 10.5772/21838

|View full text |Cite

Synthesis and In Vitro Screening of Novel Heterocyclic Compounds as Potential Breast Cancer Agents

Narsimha Reddy Penthala¹,

Thirupathi Reddy Yerramreddy²,

Nikhil Reddy Madadi³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt

Abo-Salem

Gibriel

Al-Awady

et al. 2020

View full text Add to dashboard Cite

Background: Flavonoids are naturally occurring compounds with versatile health-promoting effects against various diseases. Objective: To synthesize and evaluate biological activity of novel flavone derivatives against cancer. Methods: A new series of 2-hydroxy-α,β-unsaturated ketones 2a-h was synthesized via the reaction of N-substituted-indole-3-carboxaldehydes 1a-h with 2-hydroxy acetophenone in the presence of piperidine. The oxidative cyclization of 2a-h using hydrogen peroxide/KOH and/or dimethyl sulfoxide/I2 produced the corresponding 2-(N-substituted-1H-indol-3-yl)-3-hydroxy-4H-chromen-4-ones 3a-h and 2-(N-substituted-1H-indol-3-yl)-4H-chromen-4-ones 4a-h respectively. Anti-proliferative activities for synthesized series were investigated against HCT-116 colon and MCF-7 breast cancer cell lines. Molecular downstream effects were evaluated using RT-PCR. Moreover, molecular docking was carried out to pinpoint the binding mode of the most active compounds into the active site of Akt enzyme (PDB ID: 3QKK). Results: All compounds exhibited anti-proliferative activity range of 52-97% and 67.2-99% against HCT-116 and MCF-7 respectively. Compounds 3b, 3h, 3g and 4h had minimal inhibitory effect on normal BJ1 cells indicating their safety profile. Compounds 3b and 4h in particular exhibited the most potent antiproliferative activity against HCT116 and MCF7, meanwhile compounds 3g, 3h and 4g showed potent to moderate activity. Compound 3b had IC50 of 78.3 µM and 53.9 µM against HCT-116 and MCF-7 respectively with comparable IC50 for doxorubicin of 65.1 µM and 45.02 µM respectively. Compound 3b exhibited significant down-regulation for Akt and significant up-regulation of CAS9 and CDKN1genes in all tested cell lines. Conclusion: The synthesized flavone derivatives and particularly compound 3b exhibited promising anticancer activity through Akt inhibition.

show abstract

Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt

Abo-Salem

Gibriel

Al-Awady

et al. 2020

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Synthesis and In Vitro Screening of Novel Heterocyclic Compounds as Potential Breast Cancer Agents

Cited by 1 publication

References 10 publications

Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt

Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt

Contact Info

Product

Resources

About